# T900607 in Treating Patients With Gastroesophageal Junction Cancer

> **NCT00054249** · PHASE2 · COMPLETED · sponsor: **University Hospitals Seidman Cancer Center**

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** T900607

## Key facts

- **NCT ID:** NCT00054249
- **Lead sponsor:** University Hospitals Seidman Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** 2004-10
- **Final completion:** 2010-09
- **Target enrollment:** — (—)
- **Last updated:** 2013-07-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00054249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00054249, "T900607 in Treating Patients With Gastroesophageal Junction Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00054249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*